Global Oral Contraceptive Market Insights and Forecast to 2026

Publisher Name :
Date: 18-Aug-2020
No. of pages: 110
Inquire Before Buying

Oral Contraceptive market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Oral Contraceptive market is segmented into

- Combination

- Progestin Only

- Others

Segment by Application, the Oral Contraceptive market is segmented into

- Male

- Female

Regional and Country-level Analysis

The Oral Contraceptive market is analysed and market size information is provided by regions (countries).

The key regions covered in the Oral Contraceptive market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Oral Contraceptive Market Share Analysis

Oral Contraceptive market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Contraceptive business, the date to enter into the Oral Contraceptive market, Oral Contraceptive product introduction, recent developments, etc.

The major vendors covered:

- Pfizer, Inc.

- Bayer AG

- Merck & Co., Inc.

- Janssen Global Services, LLC

- Mankind Pharma Ltd.

- Teva Pharmaceutical Industries Ltd

- Allergan, plc (Actavis)

- Piramal Enterprises Ltd.

- Beijing Zizhu Pharm

Global Oral Contraceptive Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Oral Contraceptive Product Introduction
1.2 Market Segments
1.3 Key Oral Contraceptive Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oral Contraceptive Market Size Growth Rate by Type
1.4.2 Combination
1.4.3 Progestin Only
1.4.4 Others
1.5 Market by Application
1.5.1 Global Oral Contraceptive Market Size Growth Rate by Application
1.5.2 Male
1.5.3 Female
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oral Contraceptive Market Size, Estimates and Forecasts
2.1.1 Global Oral Contraceptive Revenue 2015-2026
2.1.2 Global Oral Contraceptive Sales 2015-2026
2.2 Global Oral Contraceptive, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oral Contraceptive Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oral Contraceptive Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oral Contraceptive Competitor Landscape by Players
3.1 Oral Contraceptive Sales by Manufacturers
3.1.1 Oral Contraceptive Sales by Manufacturers (2015-2020)
3.1.2 Oral Contraceptive Sales Market Share by Manufacturers (2015-2020)
3.2 Oral Contraceptive Revenue by Manufacturers
3.2.1 Oral Contraceptive Revenue by Manufacturers (2015-2020)
3.2.2 Oral Contraceptive Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Contraceptive Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oral Contraceptive Revenue in 2019
3.2.5 Global Oral Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oral Contraceptive Price by Manufacturers
3.4 Oral Contraceptive Manufacturing Base Distribution, Product Types
3.4.1 Oral Contraceptive Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Contraceptive Product Type
3.4.3 Date of International Manufacturers Enter into Oral Contraceptive Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oral Contraceptive Market Size by Type (2015-2020)
4.1.1 Global Oral Contraceptive Sales by Type (2015-2020)
4.1.2 Global Oral Contraceptive Revenue by Type (2015-2020)
4.1.3 Oral Contraceptive Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oral Contraceptive Market Size Forecast by Type (2021-2026)
4.2.1 Global Oral Contraceptive Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Contraceptive Revenue Forecast by Type (2021-2026)
4.2.3 Oral Contraceptive Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oral Contraceptive Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Oral Contraceptive Market Size by Application (2015-2020)
5.1.1 Global Oral Contraceptive Sales by Application (2015-2020)
5.1.2 Global Oral Contraceptive Revenue by Application (2015-2020)
5.1.3 Oral Contraceptive Price by Application (2015-2020)
5.2 Oral Contraceptive Market Size Forecast by Application (2021-2026)
5.2.1 Global Oral Contraceptive Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Contraceptive Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Contraceptive Price Forecast by Application (2021-2026)
6 North America
6.1 North America Oral Contraceptive by Country
6.1.1 North America Oral Contraceptive Sales by Country
6.1.2 North America Oral Contraceptive Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oral Contraceptive Market Facts & Figures by Type
6.3 North America Oral Contraceptive Market Facts & Figures by Application
7 Europe
7.1 Europe Oral Contraceptive by Country
7.1.1 Europe Oral Contraceptive Sales by Country
7.1.2 Europe Oral Contraceptive Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Contraceptive Market Facts & Figures by Type
7.3 Europe Oral Contraceptive Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Oral Contraceptive by Region
8.1.1 Asia Pacific Oral Contraceptive Sales by Region
8.1.2 Asia Pacific Oral Contraceptive Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oral Contraceptive Market Facts & Figures by Type
8.3 Asia Pacific Oral Contraceptive Market Facts & Figures by Application
9 Latin America
9.1 Latin America Oral Contraceptive by Country
9.1.1 Latin America Oral Contraceptive Sales by Country
9.1.2 Latin America Oral Contraceptive Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oral Contraceptive Market Facts & Figures by Type
9.3 Central & South America Oral Contraceptive Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Oral Contraceptive by Country
10.1.1 Middle East and Africa Oral Contraceptive Sales by Country
10.1.2 Middle East and Africa Oral Contraceptive Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oral Contraceptive Market Facts & Figures by Type
10.3 Middle East and Africa Oral Contraceptive Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Corporation Information
11.1.2 Pfizer, Inc. Description and Business Overview
11.1.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer, Inc. Oral Contraceptive Products Offered
11.1.5 Pfizer, Inc. Related Developments
11.2 Bayer AG
11.2.1 Bayer AG Corporation Information
11.2.2 Bayer AG Description and Business Overview
11.2.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer AG Oral Contraceptive Products Offered
11.2.5 Bayer AG Related Developments
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Corporation Information
11.3.2 Merck & Co., Inc. Description and Business Overview
11.3.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck & Co., Inc. Oral Contraceptive Products Offered
11.3.5 Merck & Co., Inc. Related Developments
11.4 Janssen Global Services, LLC
11.4.1 Janssen Global Services, LLC Corporation Information
11.4.2 Janssen Global Services, LLC Description and Business Overview
11.4.3 Janssen Global Services, LLC Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Janssen Global Services, LLC Oral Contraceptive Products Offered
11.4.5 Janssen Global Services, LLC Related Developments
11.5 Mankind Pharma Ltd.
11.5.1 Mankind Pharma Ltd. Corporation Information
11.5.2 Mankind Pharma Ltd. Description and Business Overview
11.5.3 Mankind Pharma Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mankind Pharma Ltd. Oral Contraceptive Products Offered
11.5.5 Mankind Pharma Ltd. Related Developments
11.6 Teva Pharmaceutical Industries Ltd
11.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
11.6.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teva Pharmaceutical Industries Ltd Oral Contraceptive Products Offered
11.6.5 Teva Pharmaceutical Industries Ltd Related Developments
11.7 Allergan, plc (Actavis)
11.7.1 Allergan, plc (Actavis) Corporation Information
11.7.2 Allergan, plc (Actavis) Description and Business Overview
11.7.3 Allergan, plc (Actavis) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Allergan, plc (Actavis) Oral Contraceptive Products Offered
11.7.5 Allergan, plc (Actavis) Related Developments
11.8 Piramal Enterprises Ltd.
11.8.1 Piramal Enterprises Ltd. Corporation Information
11.8.2 Piramal Enterprises Ltd. Description and Business Overview
11.8.3 Piramal Enterprises Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Piramal Enterprises Ltd. Oral Contraceptive Products Offered
11.8.5 Piramal Enterprises Ltd. Related Developments
11.9 Beijing Zizhu Pharm
11.9.1 Beijing Zizhu Pharm Corporation Information
11.9.2 Beijing Zizhu Pharm Description and Business Overview
11.9.3 Beijing Zizhu Pharm Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Beijing Zizhu Pharm Oral Contraceptive Products Offered
11.9.5 Beijing Zizhu Pharm Related Developments
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Corporation Information
11.1.2 Pfizer, Inc. Description and Business Overview
11.1.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer, Inc. Oral Contraceptive Products Offered
11.1.5 Pfizer, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oral Contraceptive Market Estimates and Projections by Region
12.1.1 Global Oral Contraceptive Sales Forecast by Regions 2021-2026
12.1.2 Global Oral Contraceptive Revenue Forecast by Regions 2021-2026
12.2 North America Oral Contraceptive Market Size Forecast (2021-2026)
12.2.1 North America: Oral Contraceptive Sales Forecast (2021-2026)
12.2.2 North America: Oral Contraceptive Revenue Forecast (2021-2026)
12.2.3 North America: Oral Contraceptive Market Size Forecast by Country (2021-2026)
12.3 Europe Oral Contraceptive Market Size Forecast (2021-2026)
12.3.1 Europe: Oral Contraceptive Sales Forecast (2021-2026)
12.3.2 Europe: Oral Contraceptive Revenue Forecast (2021-2026)
12.3.3 Europe: Oral Contraceptive Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oral Contraceptive Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oral Contraceptive Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oral Contraceptive Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oral Contraceptive Market Size Forecast by Region (2021-2026)
12.5 Latin America Oral Contraceptive Market Size Forecast (2021-2026)
12.5.1 Latin America: Oral Contraceptive Sales Forecast (2021-2026)
12.5.2 Latin America: Oral Contraceptive Revenue Forecast (2021-2026)
12.5.3 Latin America: Oral Contraceptive Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oral Contraceptive Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oral Contraceptive Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oral Contraceptive Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oral Contraceptive Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Oral Contraceptive Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Contraceptive Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Oral Contraceptive Market Segments
Table 2. Ranking of Global Top Oral Contraceptive Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oral Contraceptive Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Combination
Table 5. Major Manufacturers of Progestin Only
Table 6. Major Manufacturers of Others
Table 7. Global Oral Contraceptive Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Oral Contraceptive Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Oral Contraceptive Sales by Regions 2015-2020 (K Units)
Table 10. Global Oral Contraceptive Sales Market Share by Regions (2015-2020)
Table 11. Global Oral Contraceptive Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Oral Contraceptive Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Oral Contraceptive Sales Share by Manufacturers (2015-2020)
Table 14. Global Oral Contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Oral Contraceptive by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Contraceptive as of 2019)
Table 16. Oral Contraceptive Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Oral Contraceptive Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Oral Contraceptive Price (2015-2020) (USD/Unit)
Table 19. Oral Contraceptive Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Oral Contraceptive Product Type
Table 21. Date of International Manufacturers Enter into Oral Contraceptive Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Oral Contraceptive Sales by Type (2015-2020) (K Units)
Table 24. Global Oral Contraceptive Sales Share by Type (2015-2020)
Table 25. Global Oral Contraceptive Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Oral Contraceptive Revenue Share by Type (2015-2020)
Table 27. Oral Contraceptive Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Oral Contraceptive Sales by Application (2015-2020) (K Units)
Table 29. Global Oral Contraceptive Sales Share by Application (2015-2020)
Table 30. North America Oral Contraceptive Sales by Country (2015-2020) (K Units)
Table 31. North America Oral Contraceptive Sales Market Share by Country (2015-2020)
Table 32. North America Oral Contraceptive Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Oral Contraceptive Revenue Market Share by Country (2015-2020)
Table 34. North America Oral Contraceptive Sales by Type (2015-2020) (K Units)
Table 35. North America Oral Contraceptive Sales Market Share by Type (2015-2020)
Table 36. North America Oral Contraceptive Sales by Application (2015-2020) (K Units)
Table 37. North America Oral Contraceptive Sales Market Share by Application (2015-2020)
Table 38. Europe Oral Contraceptive Sales by Country (2015-2020) (K Units)
Table 39. Europe Oral Contraceptive Sales Market Share by Country (2015-2020)
Table 40. Europe Oral Contraceptive Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Oral Contraceptive Revenue Market Share by Country (2015-2020)
Table 42. Europe Oral Contraceptive Sales by Type (2015-2020) (K Units)
Table 43. Europe Oral Contraceptive Sales Market Share by Type (2015-2020)
Table 44. Europe Oral Contraceptive Sales by Application (2015-2020) (K Units)
Table 45. Europe Oral Contraceptive Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Oral Contraceptive Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Oral Contraceptive Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Oral Contraceptive Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Oral Contraceptive Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Oral Contraceptive Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Oral Contraceptive Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Oral Contraceptive Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Oral Contraceptive Sales Market Share by Application (2015-2020)
Table 54. Latin America Oral Contraceptive Sales by Country (2015-2020) (K Units)
Table 55. Latin America Oral Contraceptive Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Oral Contraceptive Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Oral Contraceptive Revenue Market Share by Country (2015-2020)
Table 58. Latin America Oral Contraceptive Sales by Type (2015-2020) (K Units)
Table 59. Latin America Oral Contraceptive Sales Market Share by Type (2015-2020)
Table 60. Latin America Oral Contraceptive Sales by Application (2015-2020) (K Units)
Table 61. Latin America Oral Contraceptive Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Oral Contraceptive Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Oral Contraceptive Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Oral Contraceptive Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Oral Contraceptive Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Oral Contraceptive Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Oral Contraceptive Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Oral Contraceptive Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Oral Contraceptive Sales Market Share by Application (2015-2020)
Table 70. Pfizer, Inc. Corporation Information
Table 71. Pfizer, Inc. Description and Major Businesses
Table 72. Pfizer, Inc. Oral Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Pfizer, Inc. Product
Table 74. Pfizer, Inc. Recent Development
Table 75. Bayer AG Corporation Information
Table 76. Bayer AG Description and Major Businesses
Table 77. Bayer AG Oral Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Bayer AG Product
Table 79. Bayer AG Recent Development
Table 80. Merck & Co., Inc. Corporation Information
Table 81. Merck & Co., Inc. Description and Major Businesses
Table 82. Merck & Co., Inc. Oral Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Merck & Co., Inc. Product
Table 84. Merck & Co., Inc. Recent Development
Table 85. Janssen Global Services, LLC Corporation Information
Table 86. Janssen Global Services, LLC Description and Major Businesses
Table 87. Janssen Global Services, LLC Oral Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Janssen Global Services, LLC Product
Table 89. Janssen Global Services, LLC Recent Development
Table 90. Mankind Pharma Ltd. Corporation Information
Table 91. Mankind Pharma Ltd. Description and Major Businesses
Table 92. Mankind Pharma Ltd. Oral Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Mankind Pharma Ltd. Product
Table 94. Mankind Pharma Ltd. Recent Development
Table 95. Teva Pharmaceutical Industries Ltd Corporation Information
Table 96. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 97. Teva Pharmaceutical Industries Ltd Oral Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Teva Pharmaceutical Industries Ltd Product
Table 99. Teva Pharmaceutical Industries Ltd Recent Development
Table 100. Allergan, plc (Actavis) Corporation Information
Table 101. Allergan, plc (Actavis) Description and Major Businesses
Table 102. Allergan, plc (Actavis) Oral Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Allergan, plc (Actavis) Product
Table 104. Allergan, plc (Actavis) Recent Development
Table 105. Piramal Enterprises Ltd. Corporation Information
Table 106. Piramal Enterprises Ltd. Description and Major Businesses
Table 107. Piramal Enterprises Ltd. Oral Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Piramal Enterprises Ltd. Product
Table 109. Piramal Enterprises Ltd. Recent Development
Table 110. Beijing Zizhu Pharm Corporation Information
Table 111. Beijing Zizhu Pharm Description and Major Businesses
Table 112. Beijing Zizhu Pharm Oral Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Beijing Zizhu Pharm Product
Table 114. Beijing Zizhu Pharm Recent Development
Table 115. Global Oral Contraceptive Sales Forecast by Regions (2021-2026) (K Units)
Table 116. Global Oral Contraceptive Sales Market Share Forecast by Regions (2021-2026)
Table 117. Global Oral Contraceptive Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 118. Global Oral Contraceptive Revenue Market Share Forecast by Regions (2021-2026)
Table 119. North America: Oral Contraceptive Sales Forecast by Country (2021-2026) (K Units)
Table 120. North America: Oral Contraceptive Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Europe: Oral Contraceptive Sales Forecast by Country (2021-2026) (K Units)
Table 122. Europe: Oral Contraceptive Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Asia Pacific: Oral Contraceptive Sales Forecast by Region (2021-2026) (K Units)
Table 124. Asia Pacific: Oral Contraceptive Revenue Forecast by Region (2021-2026) (US$ Million)
Table 125. Latin America: Oral Contraceptive Sales Forecast by Country (2021-2026) (K Units)
Table 126. Latin America: Oral Contraceptive Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Middle East and Africa: Oral Contraceptive Sales Forecast by Country (2021-2026) (K Units)
Table 128. Middle East and Africa: Oral Contraceptive Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 130. Key Challenges
Table 131. Market Risks
Table 132. Main Points Interviewed from Key Oral Contraceptive Players
Table 133. Oral Contraceptive Customers List
Table 134. Oral Contraceptive Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Contraceptive Product Picture
Figure 2. Global Oral Contraceptive Sales Market Share by Type in 2020 & 2026
Figure 3. Combination Product Picture
Figure 4. Progestin Only Product Picture
Figure 5. Others Product Picture
Figure 6. Global Oral Contraceptive Sales Market Share by Application in 2020 & 2026
Figure 7. Male
Figure 8. Female
Figure 9. Oral Contraceptive Report Years Considered
Figure 10. Global Oral Contraceptive Market Size 2015-2026 (US$ Million)
Figure 11. Global Oral Contraceptive Sales 2015-2026 (K Units)
Figure 12. Global Oral Contraceptive Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Oral Contraceptive Sales Market Share by Region (2015-2020)
Figure 14. Global Oral Contraceptive Sales Market Share by Region in 2019
Figure 15. Global Oral Contraceptive Revenue Market Share by Region (2015-2020)
Figure 16. Global Oral Contraceptive Revenue Market Share by Region in 2019
Figure 17. Global Oral Contraceptive Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Oral Contraceptive Revenue in 2019
Figure 19. Oral Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Oral Contraceptive Sales Market Share by Type (2015-2020)
Figure 21. Global Oral Contraceptive Sales Market Share by Type in 2019
Figure 22. Global Oral Contraceptive Revenue Market Share by Type (2015-2020)
Figure 23. Global Oral Contraceptive Revenue Market Share by Type in 2019
Figure 24. Global Oral Contraceptive Market Share by Price Range (2015-2020)
Figure 25. Global Oral Contraceptive Sales Market Share by Application (2015-2020)
Figure 26. Global Oral Contraceptive Sales Market Share by Application in 2019
Figure 27. Global Oral Contraceptive Revenue Market Share by Application (2015-2020)
Figure 28. Global Oral Contraceptive Revenue Market Share by Application in 2019
Figure 29. North America Oral Contraceptive Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Oral Contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Oral Contraceptive Sales Market Share by Country in 2019
Figure 32. North America Oral Contraceptive Revenue Market Share by Country in 2019
Figure 33. U.S. Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Oral Contraceptive Market Share by Type in 2019
Figure 38. North America Oral Contraceptive Market Share by Application in 2019
Figure 39. Europe Oral Contraceptive Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Oral Contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Oral Contraceptive Sales Market Share by Country in 2019
Figure 42. Europe Oral Contraceptive Revenue Market Share by Country in 2019
Figure 43. Germany Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Oral Contraceptive Market Share by Type in 2019
Figure 54. Europe Oral Contraceptive Market Share by Application in 2019
Figure 55. Asia Pacific Oral Contraceptive Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Oral Contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Oral Contraceptive Sales Market Share by Region in 2019
Figure 58. Asia Pacific Oral Contraceptive Revenue Market Share by Region in 2019
Figure 59. China Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Oral Contraceptive Market Share by Type in 2019
Figure 82. Asia Pacific Oral Contraceptive Market Share by Application in 2019
Figure 83. Latin America Oral Contraceptive Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Oral Contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Oral Contraceptive Sales Market Share by Country in 2019
Figure 86. Latin America Oral Contraceptive Revenue Market Share by Country in 2019
Figure 87. Mexico Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Oral Contraceptive Market Share by Type in 2019
Figure 94. Latin America Oral Contraceptive Market Share by Application in 2019
Figure 95. Middle East and Africa Oral Contraceptive Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Oral Contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Oral Contraceptive Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Oral Contraceptive Revenue Market Share by Country in 2019
Figure 99. Turkey Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Oral Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Oral Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Oral Contraceptive Market Share by Type in 2019
Figure 106. Middle East and Africa Oral Contraceptive Market Share by Application in 2019
Figure 107. North America Oral Contraceptive Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Oral Contraceptive Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Oral Contraceptive Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Oral Contraceptive Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Oral Contraceptive Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Oral Contraceptive Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Oral Contraceptive Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Oral Contraceptive Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Oral Contraceptive Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Oral Contraceptive Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs